Brokerages Set Verve Therapeutics, Inc. (NASDAQ:VERV) PT at $30.00

Verve Therapeutics, Inc. (NASDAQ:VERV – Get Free Report) has received an average recommendation of “Hold” from the seven ratings firms that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and four have assigned a buy recommendation to the […]

Leave a Reply

Your email address will not be published.

Previous post Tidewater Midstream and Infrastructure Ltd. (TSE:TWM) Receives C$1.37 Average PT from Analysts
Next post MLB Notes: What we know about Yoshinobu Yamamoto’s free agency